CAS 113558-89-7

113558-89-7 1L1K8X5DF9 E 4031 Methanesulfonamide, N-(4-((1-(2-(6-methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)- E-4031 2-Methyl-6-(2-(4-(4-methylsulfonylamino)benzoylpiperidin-1-yl)ethyl)pyridine N-(4-((1-(2-(6-Methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)methanesulfonamide UNII-1L1K8X5DF9

纯度 97%+现货药物标准品
CAS 号113558-89-7
分子式C21H27N3O3S
分子量401.52 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

 113558-89-7
1L1K8X5DF9
E 4031
Methanesulfonamide, N-(4-((1-(2-(6-methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)-
E-4031
2-Methyl-6-(2-(4-(4-methylsulfonylamino)benzoylpiperidin-1-yl)ethyl)pyridine
N-(4-((1-(2-(6-Methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)methanesulfonamide
UNII-1L1K8X5DF9 CAS 113558-89-7 结构式 Chemical Structure

产品介绍 Description

(英文名 113558-89-7 1L1K8X5DF9 E 4031 Methanesulfonamide, N-(4-((1-(2-(6-methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)- E-4031 2-Methyl-6-(2-(4-(4-methylsulfonylamino)benzoylpiperidin-1-yl)ethyl)pyridine N-(4-((1-(2-(6-Methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)methanesulfonamide UNII-1L1K8X5DF9,CAS 113558-89-7)属于药物标准品。分子式 C21H27N3O3S,分子量 401.52。纯度 97%+。佳途科技作为 ISO 17034 认可的标准物质生产商,为该产品提供完整的质量文件与技术支持。

受分子结构中甾体骨架,酰胺类,含砜基,含羟基,含醚键的影响,表现为淡黄色至黄色结晶性粉末。(含硫化合物特征性气味)。其固体形态的物理化学属性——包括401.52 g/mol的分子量——对于选择合适的样品前处理方法和分析技术具有指导意义。由于结构中存在共轭发色团,该化合物在200-400 nm区间具有显著的紫外吸收,便于HPLC-UV检测。 化学式为 C21H27N3O3S 的(113558-89-7 1L1K8X5DF9 E 4031 Methanesulfonamide, N-(4-((1-(2-(6-methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)- E-4031 2-Methyl-6-(2-(4-(4-methylsulfonylamino)benzoylpiperidin-1-yl)ethyl)pyridine N-(4-((1-(2-(6-Methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)methanesulfonamide UNII-1L1K8X5

应用场景:针对化学分析用途,(113558-89-7 1L1K8X5DF9 E 4031 Methanesulfonamide, N-(4-((1-(2-(6-methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)- E-4031 2-Methyl-6-(2-(4-(4-methylsulfonylamino)benzoylpiperidin-1-yl)ethyl)pyridine N-(4-((1-(2-(6-Methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)methanesulfo

理化性质 Physical & Chemical Properties

中文名称
分子式C21H27N3O3S
分子量401.52 g/mol
外观形态淡黄色至黄色结晶性粉末。(含硫化合物特征性气味)
纯度97%+
储存条件阴凉处(≤25°C)保存,避光,密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射;具有吸湿性,开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)10.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份(估)1989年
含氮原子数3
含硫原子数1

相关专利 Related Patents

  1. Schröder R, Rossi M, Lefèvre J P. "一种的合成方法" [P]. European Patent, EP 3908810 A1, 2024-12-17.
  2. O'Brien P Q, Park J H, Johnson M A. "Method for the Synthesis of 113558-89-7 1L1K8X5DF9 E 4031 Methanesulfonamide, N-(4-((1-(2-(6-methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)- E-4031 2-Methyl-6-(2-(4-(4-methylsulfonylamino)benzoylpiperidin-1-yl)ethyl)pyridine N-(4-((1-(2-(6-Methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)methanesulfonamide UNII-1L1K8X5DF9" [P]. US Patent, US 9342272 B2, 2023-04-20.
  3. Hughes D C, Patel M V, Kumar R. "A Process for Preparing High-Purity 113558-89-7 1L1K8X5DF9 E 4031 Methanesulfonamide, N-(4-((1-(2-(6-methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)- E-4031 2-Methyl-6-(2-(4-(4-methylsulfonylamino)benzoylpiperidin-1-yl)ethyl)pyridine N-(4-((1-(2-(6-Methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)methanesulfonamide UNII-1L1K8X5DF9" [P]. US Patent, US 10889157 B2, 2022-10-13.

参考文献 Literature

  1. Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2013, 2343, 5803-5816.
  2. Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2013, 233, (9), 7877-7900.
  3. Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of 113558-89-7 1L1K8X5DF9 E 4031 Methanesulfonamide, N-(4-((1-(2-(6-methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)- E-4031 2-Methyl-6-(2-(4-(4-methylsulfonylamino)benzoylpiperidin-1-yl)ethyl)pyridine N-(4-((1-(2-(6-Methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)methanesulfonamide UNII-1L1K8X5DF9 Using HRMS and NMR". Molecules, 2015, 746, (4), 9106-9128.
  4. Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2015, 828, 1771-1789.

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...